But the steady rise in prices for branded drugs contributes indirectly to rises in premiums, deductibles and government health spending, analysts say
Experts and regulators warn consumers to be cautious and are raising red flags about one set of limited benefit plans marketed to individuals for as little as $93 a month
About 40 percent of the hospitals in the U.S. now buy drugs through the program, according to the 2015 GAO report
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: